Skip to main content
. 2020 Mar 26;11(12):3596–3603. doi: 10.7150/jca.35738

Table 2.

Positive cases for PDL1 according to subtype of RCCs

Subtype of RCC Number of Patients (N:172) Positive Cases for PDL1 Mean Positivity of PD-L1 in Tumor Cells
HLRCC 53 31 (58.4%) 34.5%
Clear Cell RCC (VHL) 34 0 (0%) 0 %
Type 1 PRCC 31 10 (32.2%) 41.1%
Chromophobe RCC 20 7 (35.0%) 25.7%
Hybrid Tumor 9 3 (33.3%) 30%
RCC-TFE3 8 3 (37.5%) 56.7%
Oncocytoma 7 0 (0%) 0 %
Undifferentiated 5 3 (60%) 38.3%
RCC with SDHB mutation 3 0 (0%) 0%
TFEB-RCC 2 2 (100%) 55%
Total 172 59